Plain-English translation of NCT07220538 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether Extract of Ginkgo Biloba Leaves Tablets can help people recover thinking and memory skills after a stroke. You would take this medication in addition to your regular stroke treatments. The study will follow you for one year to see if the medication helps your brain recover better than standard care alone.
After a stroke, many people experience problems with memory and thinking skills that can affect their daily lives. This medication exists to see whether this herbal supplement can help the brain heal and restore these abilities better than current standard treatments alone.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to either take the ginkgo biloba extract (240 mg per day in three doses) plus your regular stroke treatments, or to continue with standard care alone. Over 52 weeks, you would visit the hospital at scheduled times for follow-up appointments where doctors check your recovery, test your memory and thinking, and monitor how you're doing. The study team will assess your progress and watch for any side effects throughout the year.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
China